Glycemic control in type 2 diabetic patients during the COVID-19 virus pandemic

Kanyakamon Kunkitikad, Veerasak Sarinnapakorn *, Chaicharn Deerochanawong, Sathit Niramitmahapanya, Navaporn Napartivaumnuay and Thitinan Treesaranuwattana

Endocrinology Unit, Department of Medicine, Rajavithi Hospital. College of Medicine, Rangsit University, Bangkok, 10400. Thailand.
 
Research Article
GSC Advanced Research and Reviews, 2021, 09(01), 094–0103.
Article DOI: 10.30574/gscarr.2021.9.1.0238
Publication history: 
Received on 09 September 2021; revised on 13 October 2021; accepted on 15 October 2021
 
Abstract: 
Background: The Coronavirus disease 2019 (COVID-19) disease is a pandemic disease spread worldwide and results in lifestyle changes in areas affected by COVID-19. The ongoing social distancing and lockdowns may negatively impact access to medical care and management of type 2 diabetes mellitus (T2DM). Accordingly, we examined the impact of the COVID-19 virus pandemic in Thailand on the glycemic control of patients with T2DM.
Method: This study focused on T2DM outpatients at Rajavithi Hospital. Three hundred and fifty participants were included. Baseline characteristics, data on exercise, outdoor activities, and access to foods and blood chemistries, including hemoglobin A1C (A1C) and fasting plasma glucose (FPG), were reviewed, and collected from electronic medical records before and after the COVID-19 pandemic.
Results: There was a significant increase in mean A1C (g/L) ± SD (74.8 ± 13.7 vs. 76.0 ± 15.3, p-value <0.016), the mean duration of outdoor activities (hours/day) ± SD during the COVID-19 virus pandemic was significantly decreased. (5.35 ± 4.48 vs. 4.03 ± 4.37, p-value <0.001)
Conclusion: The present study showed that mean A1C was significantly increased during the COVID-19 virus pandemic. Nevertheless, a statistical difference was not observed in FPG. The impact of quarantine, social distancing, and community containment during the epidemic on lifestyles may be the essential factor in increasing A1C.
 
Keywords: 
Glycemic control; Hemoglobin A1C; Fasting plasma glucose; Type 2 diabetes mellitus; Coronavirus disease 2019 (COVID-19)
 
Full text article in PDF: 
Share this